Abstract
AbstractThe evolution of SARS-CoV-2 could impair recognition of the virus by human antibody-mediated immunity. To facilitate prospective surveillance for such evolution, we map how convalescent serum antibodies are impacted by all mutations to the spike’s receptor-binding domain (RBD), the main target of serum neutralizing activity. Binding by polyclonal serum antibodies is affected by mutations in three main epitopes in the RBD, but there is substantial variation in the impact of mutations both among individuals and within the same individual over time. Despite this inter- and intra-person heterogeneity, the mutations that most reduce antibody binding usually occur at just a few sites in the RBD’s receptor binding motif. The most important site is E484, where neutralization by some sera is reduced >10-fold by several mutations, including one in emerging viral lineages in South Africa and Brazil. Going forward, these serum escape maps can inform surveillance of SARS-CoV-2 evolution.
Publisher
Cold Spring Harbor Laboratory
Reference62 articles.
1. Addetia, A. , Crawford, K.H.D. , Dingens, A. , Zhu, H. , Roychoudhury, P. , Huang, M.-L. , Jerome, K.R. , Bloom, J.D. , and Greninger, A.L. (2020). Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate. J. Clin. Microbiol. 58.
2. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
3. Andreano, E. , Piccini, G. , Licastro, D. , Casalino, L. , Johnson, N.V. , Paciello, I. , Monego, S.D. , Pantano, E. , Manganaro, N. , Manenti, A. , et al. (2020). SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma. bioRxiv 2020.12.28.424451.
4. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Nature,2020
5. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Cited by
114 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献